Skip to content

The Diagnostic Value of Multimodal Ultrasound in Colorectal liver Metastasis

The Diagnostic Value of Multimodal Ultrasound in Colorectal liver Metastasis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092844
Enrollment
Unknown
Registered
2024-11-25
Start date
2024-11-27
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal liver Metastasis

Interventions

SonoVue group:NA
Sonazoid group:NA

Sponsors

Beijing Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1) Age >=18 years old; 2) The primary lesion of bowel cancer can be resected; 3) Imaging findings of liver metastases; 4) Surgical treatment of liver metastases; 5) Neoadjuvant chemotherapy was performed from the discovery of liver metastasis to hepatectomy; 6) Get the informed consent signed.

Exclusion criteria

Exclusion criteria: 1) Pregnant, lactating or already pregnant; 2) Liver metastases cannot be shown by contrast-enhanced ultrasound; 3) Reliable measurements of SWE cannot be obtained from liver metastases or liver backgrounds; 4) Severe allergies.

Design outcomes

Primary

MeasureTime frame
Two-dimensional ultrasound findings of lesion;contrast-enhanced ultrasound findings of lesion;

Secondary

MeasureTime frame
SWE value of lesion;SWE value of liver;

Countries

China

Contacts

Public ContactYan Kun

Department of Ultrasonography, Bejing Cancer Hospital

ydbz@vip.sina.com+86 88196910

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026